Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in IMMX — Immix Biopharma, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to IMMX Full portfolio

Position in IMMX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,168,329
+$1,012,102 QoQ
Shares Held
113,320
+560.8% QoQ
Ownership
0.158%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 109 holders
Holding Since
Mar 2022
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IMMX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. IMMX ranks #128 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in IMMX

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,168,329 113,320
2026-03-31 $156,227 17,149
2025-09-30 $689 330
2025-06-30 $683 330
2025-03-31 $554 330
2024-12-31 $726 330
2024-09-30 $491 330
2024-06-30 $653 330
2024-03-31 $1,332 434
2023-12-31 $2,705 391
2023-09-30 $194 57
2023-06-30 $112 42
2023-03-31 $69 38
2022-12-31 $84 37
2022-09-30 $48 36
2022-06-30 $182 70
2022-03-31 $62 26